TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36469926

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 0
Study: 34221475

Group type: EXPERIMENTAL
Intervention: Educational support programme
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 80
Study: 32178526

Group type: EXPERIMENTAL
Intervention: DPI (rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily)
Number of subjects: 16560

Group type: COMPARATOR
Intervention: Aspirin (100 mg once daily)
Number of subjects: 16560
Study: 35849139

Group type: EXPERIMENTAL
Intervention: Telehealth diabetes prevention lifestyle program (13 telephone sessions and behavior change techniques)
Number of subjects: 1087

Group type: EXPERIMENTAL
Intervention: Behavior change techniques (BCTs)
Number of subjects: 1087

Group type: EXPERIMENTAL
Intervention: Goal setting for weight management
Number of subjects: 1087

Group type: EXPERIMENTAL
Intervention: Perceived success in reaching a healthy weight
Number of subjects: 1087
Study: 33249458

Group type: EXPERIMENTAL
Intervention: Varenicline sampling
Number of subjects: 99
Study: 34155411

Group type: EXPERIMENTAL
Intervention: gantenerumab
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: solanezumab
Number of subjects: 144

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 144
Study: 36327436

Group type: EXPERIMENTAL
Intervention: HTD1801 500 mg BID
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: HTD1801 1000 mg BID
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 32151562

Group type: EXPERIMENTAL
Intervention: 200 mg lactoferrin
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: 600 mg lactoferrin
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study: 36215873

Group type: EXPERIMENTAL
Intervention: Couple-based interpersonal psychotherapy (IPT)
Number of subjects: 455

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 455
Study: 33950222

Group type: EXPERIMENTAL
Intervention: Anodal cerebellar tDCS and cathodal spinal tDCS (real tDCS)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 61
Study: 32144049

Group type: EXPERIMENTAL
Intervention: Grade 3 recurrence
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Grade 3 progression
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: NMIBC patients
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Grade 1 recurrence
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Grade 2 recurrence
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Progression to MIBC
Number of subjects: 472
Study: 34752990

Group type: EXPERIMENTAL
Intervention: Igual-Mente program (education, contact, skill development)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Humane treatment behaviors
Number of subjects: 316
Study: 33607121

Group type: EXPERIMENTAL
Intervention: 8.25% Sodium Hypochlorite (NaOCl)
Number of subjects: 180

Group type: COMPARATOR
Intervention: 2.5% Sodium Hypochlorite (NaOCl)
Number of subjects: 180

Group type: COMPARATOR
Intervention: 5.25% Sodium Hypochlorite (NaOCl)
Number of subjects: 180

Group type: COMPARATOR
Intervention: 2% Chlorhexidine (CHX)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Preparation time ≥10 minutes
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Overfilling
Number of subjects: 180
Study: 32899001

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 35034712

Group type: EXPERIMENTAL
Intervention: Computerized intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (healthy comparisons)
Number of subjects: 300
Study: 33092501

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) administered via continuous intravenous infusion at a dosage of 90 μg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 0
Study: 35330880

Group type: EXPERIMENTAL
Intervention: Short Flex (8 ± 2 weeks)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Long Flex (14 ± 2 weeks)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Short Flex
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Short Flex and Long Flex
Number of subjects: 282
Study: 36126211

Group type: EXPERIMENTAL
Intervention: Defect bridging of the sural nerve with a venous graft
Number of subjects: 34

Group type: COMPARATOR
Intervention: No nerve reconstruction (Control)
Number of subjects: 34
Study: 34092117

Group type: EXPERIMENTAL
Intervention: Tailored rehabilitation nursing care program (RNT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 80
Study: 35184572

Group type: EXPERIMENTAL
Intervention: SBP-drop (defined as SBP<100 mm Hg or a drop from baseline of 40 mm Hg)
Number of subjects: 11226

Group type: EXPERIMENTAL
Intervention: SBP<100 mm Hg
Number of subjects: 11226

Group type: EXPERIMENTAL
Intervention: 40 mm Hg drop
Number of subjects: 11226

Group type: COMPARATOR
Intervention: Placebo group with SBP-drop
Number of subjects: 11226

Group type: EXPERIMENTAL
Intervention: Serelaxin group with SBP-drop
Number of subjects: 11226
Study: 34932665

Group type: EXPERIMENTAL
Intervention: OHES (caries‐free)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: ART (dental caries)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: ART plus OHES (dental caries)
Number of subjects: 93
Study: 35895867

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 2306

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 2306

Group type: EXPERIMENTAL
Intervention: Post-randomization HF hospitalization
Number of subjects: 2306

Group type: EXPERIMENTAL
Intervention: 12 months preceding HF hospitalization
Number of subjects: 2306

Group type: EXPERIMENTAL
Intervention: 12 months following hospitalization
Number of subjects: 2306
Study: 33096120

Group type: EXPERIMENTAL
Intervention: Grape juice group (GJG) consuming 400 ml of grape juice per day for 1 month
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo and exercise group (PLEG) with concurrent physical training
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Grape juice and exercise group (GJEG) with concurrent physical training
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Physical training protocol (for PLEG and GJEG)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Grape juice group (GJG) without exercise
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: All groups (GJG, PLEG, GJEG)
Number of subjects: 29
Study: 33426861

Group type: EXPERIMENTAL
Intervention: Probiotic mixture (Abincol) containing Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 million of living cells), and Lactobacillus delbrueckii subspecies delbrueckii LDD01 (200 million of living cells) for one month.
Number of subjects: 1118

Group type: EXPERIMENTAL
Intervention: Probiotic mixture (Abincol) for one month.
Number of subjects: 1118

Group type: COMPARATOR
Intervention: No add-on treatment (Group B).
Number of subjects: 1118
Study: 34582657

Group type: EXPERIMENTAL
Intervention: Zinc Supplement (45 mg of elemental zinc for 12 weeks)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 33109094

Group type: EXPERIMENTAL
Intervention: Dialysate at a controlled temperature of 37 °C
Number of subjects: 18

Group type: COMPARATOR
Intervention: Dialysate warmed with conventional methods
Number of subjects: 18
Study: 36228016

Group type: EXPERIMENTAL
Intervention: Resistance training with equalized total training volume (RTEV)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Resistance training with unequalized total training volume (RTUV)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Resistance training performed three times a week
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Resistance training performed once a week
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Higher RT frequency (RTUV)
Number of subjects: 24
Study: 33883008

Group type: EXPERIMENTAL
Intervention: HTL0018318 (15–35 mg/day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 32757725

Group type: EXPERIMENTAL
Intervention: Sitting Workstation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standing Workstation
Number of subjects: 40
Study: 36034730

Group type: EXPERIMENTAL
Intervention: Sacroiliac belt
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lumbar orthosis
Number of subjects: 0
Study: 32516410

Group type: EXPERIMENTAL
Intervention: HiOxy (packaged for 24 h in 80% O2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HiOxy (4 d aging)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HiOxy (20 d aging, 6 mo storage)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HiOxy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DeOxy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HiOxy (2, 4, and 6 mo storage)
Number of subjects: 36
Study: 33974991

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4925
Study: 33554323

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) membrane
Number of subjects: 27

Group type: COMPARATOR
Intervention: Deproteinised bovine bone mineral and a resorbable collagen membrane (control group)
Number of subjects: 27
Study: 32598663

Group type: EXPERIMENTAL
Intervention: Blood pressure telemonitoring and distant counseling (BPTM)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 240
Study: 34247295

Group type: EXPERIMENTAL
Intervention: Robotic rehabilitation group (RR) - 30–45 min, 5 days per week for 4 weeks
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Robotic rehabilitation group (RR)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study: 34174217

Group type: EXPERIMENTAL
Intervention: High-dose pitavastatin 4mg
Number of subjects: 12008

Group type: COMPARATOR
Intervention: Low-dose pitavastatin 1mg
Number of subjects: 12008
Study: 35481595

Group type: EXPERIMENTAL
Intervention: Cavitation and radiofrequency plus dietary regimen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cryolipolysis plus dietary regimen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dietary regimen only
Number of subjects: 60
Study: 33888596

Group type: EXPERIMENTAL
Intervention: Nicotinamide mononucleotide (NMN) supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 33658990

Group type: EXPERIMENTAL
Intervention: Crude peanut-extract (CPE) + Fructo-Oligosaccharides (FF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crude peanut-extract (CPE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CPE-matDCs with FF
Number of subjects: 0

Group type: COMPARATOR
Intervention: CPE-matDCs
Number of subjects: 0
Study: 36244610

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 114
Study: 33849582

Group type: EXPERIMENTAL
Intervention: Home-based visits with a peer supporter over a six month period, plus standard care
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 20
Study: 33439266

Group type: EXPERIMENTAL
Intervention: Prostate radiation therapy (PRT) added to androgen deprivation therapy (ADT)
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) alone
Number of subjects: 10000
Study: 32829608

Group type: EXPERIMENTAL
Intervention: Silver ion dressing
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sterile dressing
Number of subjects: 90

Group type: COMPARATOR
Intervention: Anerdian dressing
Number of subjects: 90
Study: 33502326

Group type: EXPERIMENTAL
Intervention: Smartphone-based mindfulness training (self-guided, 8-week duration)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Smartphone-based mindfulness training
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Smartphone-based mindfulness training (for nulliparous women)
Number of subjects: 168
Study: 34344312

Group type: EXPERIMENTAL
Intervention: Healthy Patterns intervention (home-based activity intervention)
Number of subjects: 200
Study: 32173165

Group type: EXPERIMENTAL
Intervention: Cartoon-assisted preparation package for endoscopy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (standard preparation)
Number of subjects: 65
Study: 35357323

Group type: EXPERIMENTAL
Intervention: Personalized treatment that tailored complexity parameters based on participants' self-reported capabilities and goals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control treatment with complexity parameters set generically based on national guidelines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personalization of suggested ride duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personalization of sports session frequency
Number of subjects: 0
Study: 33939311

Group type: EXPERIMENTAL
Intervention: Gingival recession (REC) assessment
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Gingival bleeding index (GBI) assessment
Number of subjects: 104
Study: 35164865

Group type: EXPERIMENTAL
Intervention: Teaching Recovery Techniques (TRT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 15
Study: 33086238

Group type: EXPERIMENTAL
Intervention: AZD5213 + pregabalin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33679615

Group type: EXPERIMENTAL
Intervention: Immediate FET during the first menstrual cycle after a failed fresh ET cycle
Number of subjects: 732

Group type: COMPARATOR
Intervention: Delayed FET during the second menstrual cycle after a failed fresh ET cycle
Number of subjects: 732
Study: 32043766

Group type: EXPERIMENTAL
Intervention: Surgical resection
Number of subjects: 2004

Group type: COMPARATOR
Intervention: Active surveillance
Number of subjects: 2004
Study: 33111359

Group type: EXPERIMENTAL
Intervention: Vigorous exercise (20-min cycling bout) after sleep restriction (RES)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Vigorous exercise (20-min cycling bout) after sleep fragmentation (FRAG)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (normal sleep)
Number of subjects: 9
Study: 35565786

Group type: EXPERIMENTAL
Intervention: Low-AGE diet (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Regular diabetic diet (n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-AGE diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Regular diabetic diet
Number of subjects: 40
Study: 32048028

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) applied after septoplasty
Number of subjects: 148

Group type: COMPARATOR
Intervention: Non-PRF (control group)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 148
Study: 34815219

Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg
Number of subjects: 444

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 444
Study: 33141936

Group type: EXPERIMENTAL
Intervention: Low-trigger transfusion (haemoglobin below 8.0 g/dL)
Number of subjects: 46

Group type: COMPARATOR
Intervention: High-trigger transfusion (haemoglobin below 9.7 g/dL)
Number of subjects: 46
Study: 34568637

Group type: EXPERIMENTAL
Intervention: Enhanced E‐cigarette Coaching (EEC)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Quitline treatment as usual (TAU)
Number of subjects: 96
Study: 33744844

Group type: EXPERIMENTAL
Intervention: Health IT intervention using the Patient Buddy app focusing on ascites, medications, and hepatic encephalopathy over 30 days.
Number of subjects: 349
Study: 34792188

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with Dermatophagoides farinae drops
Number of subjects: 440

Group type: COMPARATOR
Intervention: Conventional treatment (topical glucocorticoids, skin moisturizers, oral antihistamines, allergen avoidance)
Number of subjects: 440
Study: 34309241

Group type: EXPERIMENTAL
Intervention: HD201
Number of subjects: 105

Group type: COMPARATOR
Intervention: EU-Herceptin®
Number of subjects: 105

Group type: COMPARATOR
Intervention: US-Herceptin®
Number of subjects: 105
Study: 32551817

Group type: EXPERIMENTAL
Intervention: Machine learning classifier models using readily available clinical data
Number of subjects: 2747

Group type: EXPERIMENTAL
Intervention: Hyperinflammatory phenotype as classified by the model
Number of subjects: 2747

Group type: EXPERIMENTAL
Intervention: Machine learning models
Number of subjects: 2747

Group type: EXPERIMENTAL
Intervention: Clinical classifier model-assigned phenotypes
Number of subjects: 2747
Study: 34710894

Group type: EXPERIMENTAL
Intervention: Individual Metacognitive Interpersonal Therapy (MIT) combined with Group Mentalization-Based Treatment (MBT)
Number of subjects: 30
Study: 32948472

Group type: EXPERIMENTAL
Intervention: Low-intensity multifaceted antimicrobial stewardship intervention
Number of subjects: 167
Study: 32652388

Group type: EXPERIMENTAL
Intervention: Cue-reactivity paradigm with shopping-related pictures
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Craving measurement before and after the cue-reactivity paradigm
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Visual dot probe paradigm, implicit association test, affective shifting task
Number of subjects: 277
Study: 36084129

Group type: EXPERIMENTAL
Intervention: Cultural adaptation promotion resilience program (CAPRP), performed for 60 minutes, twice a week for four weeks
Number of subjects: 42
Study: 34876965

Group type: COMPARATOR
Intervention: Drainage skin-bridge sparing surgery combined with fistulotomy (CG)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Fistulotomy only (OG)
Number of subjects: 125
Study: 32124462

Group type: EXPERIMENTAL
Intervention: Learned pacing intervention
Number of subjects: 12

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 12
Study: 33632576

Group type: EXPERIMENTAL
Intervention: Barrier group (extraction, barrier, and suture)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (extraction and suture)
Number of subjects: 30
Study: 33125944

Group type: EXPERIMENTAL
Intervention: IMRT with cetuximab and avelumab (10 mg/kg day 7 and every 2 weeks) followed by avelumab every two weeks for 12 months (arm B and C)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: IMRT with cetuximab and avelumab (arm B and C)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT) with cisplatin (100 mg/m2 Q3W) (arm A)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT) with weekly cetuximab (arm D)
Number of subjects: 82
Study: 36251291

Group type: EXPERIMENTAL
Intervention: Multicomponent facilitation
Number of subjects: 3647
Study: 33693757

Group type: EXPERIMENTAL
Intervention: Preconception micronutrient supplementation
Number of subjects: 5011
Study: 33326576

Group type: EXPERIMENTAL
Intervention: HPV-vaccine arm
Number of subjects: 2153
Study: 35964211

Group type: EXPERIMENTAL
Intervention: CIMT-LE
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study: 34110960

Group type: EXPERIMENTAL
Intervention: BFR-LIX
Number of subjects: 32

Group type: COMPARATOR
Intervention: Acute occlusion
Number of subjects: 32
Study: 35246005

Group type: EXPERIMENTAL
Intervention: Silicon (Si) application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lead (Pb) application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cadmium (Cd) application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32991946

Group type: EXPERIMENTAL
Intervention: Personality-targeted motivational interviewing intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 36042627

Group type: EXPERIMENTAL
Intervention: Whey protein (10 g/d) with resistance training (3 times a week)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (10 g/d) with resistance training (3 times a week)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both interventions (RT+WP and RT+placebo)
Number of subjects: 45
Study: 32940689

Group type: EXPERIMENTAL
Intervention: Palbociclib plus fulvestrant
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo plus fulvestrant
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: High circulating tumor fraction
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: TP53 mutation
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: FGFR1 amplification
Number of subjects: 459
Study: 35658926

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Yi Jin Jing
Number of subjects: 90

Group type: COMPARATOR
Intervention: Combined oral contraceptives (Control)
Number of subjects: 90
Study: 32062521

Group type: EXPERIMENTAL
Intervention: 12-week exercise training intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 22
Study: 34913959

Group type: EXPERIMENTAL
Intervention: Apatinib 500 mg/d
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 33289973

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (800 mg once, followed by 400 mg daily for 6 days)
Number of subjects: 2314

Group type: COMPARATOR
Intervention: Usual care (no specific therapy)
Number of subjects: 2314

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 2314

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2314
Study: 32243574

Group type: EXPERIMENTAL
Intervention: O-R electric toothbrush with micro-vibrations
Number of subjects: 27

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 27
Study: 35982468

Group type: EXPERIMENTAL
Intervention: Personalised instant messaging (PIM)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Regular instant messaging (RIM)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Optional combined interventions (multi-media messages, nicotine replacement therapy sampling, financial incentive for active referral, phone counselling, and family/peer support group chat)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Continued-PIM
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: PIM
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Continued-RIM
Number of subjects: 1200
Study: 33103916

Group type: EXPERIMENTAL
Intervention: Gait training using a peroneal nerve stimulation device
Number of subjects: 119

Group type: COMPARATOR
Intervention: Gait training without the device (control)
Number of subjects: 119